The Future of Nuclear Medicine Training

TriMed Staff | | Health Imaging | Diagnostic Imaging
Sunday, June 5 | 4:15 AM - 5:45 PM
Room 006CD

Objectives
Upon completion of this activity, the participant will be able to:
1. Describe the advantages and disadvantages of an integrated training pathway for nuclear medicine and diagnostic radiology.
2. Discuss the importance of a transparent, credible system for lifelong learning.
3. Envision future training pathways in nuclear medicine that may best serve patients and the profession.
4. Review trends in nuclear medicine practice that will influence nuclear medicine training.

Speakers are:
Lale Kostakoglu, MD, MPH, Mount Sinai Medical Center in New York City;
Henry D. Royal, MD, Washington University School of Medicine in St. Louis, Mo.;
Christopher J. Palestro, MD, North Shore Long Island Jewish Health System in Manhasset N.Y.;
Missy Fleming, PhD, Accreditation Council for Graduate Medical Education; and
Milton J. Guiberteau, MD, St. Joseph Medical Center in Houston.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.